"For a high business growth and thriving sustainability in the market, a market research report e.g. Oncology Molecular Diagnostic Market report, containing detailed statistics and market research insights is always crucial. The market definition topic of this report covers, market drivers indicating the factors causing rise in the market growth and market restraints which indicate the factors causing fall in the market growth. Whereas, competitive analysis covers the strategies used by the major competitors in the market that perks up their penetration in the market. These strategies consist of new product launches, expansions, agreements, joint ventures, partnerships, to acquisitions..
The persuasive Oncology Molecular Diagnostic Market analysis report makes available the current and forthcoming technical and financial details of the industry. This market survey report also offers information about consumer’s demands, preferences, and their variable likings about particular product. All the data and information involved in this report has been represented very well in the form of graphs, charts or tables for the better understanding of users. Moreover, only dependable sources such as journals, newspapers, company websites and annual reports of the companies have been referred to collect the data in the first class Oncology Molecular Diagnostic Market business report which can be trusted confidently.
Data Bridge Market Research analyses that the oncology molecular diagnostic market which was USD 3.69 billion in 2022, is expected to reach USD 11.45 billion by 2030, at a CAGR of 15.2% during the forecast period 2023 to 2030.
Explore Further Details about This Research Oncology Molecular Diagnostic Market Report https://www.databridgemarketresearch.com/reports/global-oncology-molecular-diagnostic-market
Oncology Molecular Diagnostic Market Scope and Segmentation
REPORT METRIC | DETAILS |
Forecast Period | 2023 to 2030 |
Base Year | 2022 |
Historic Years | 2021 (Customizable to 2015 - 2020) |
Quantitative Units | Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered | Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Others), Product (Instruments, Reagents, Others), Test Location (Clinics and Other Establishments, Point of Care), Technology (PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others), End User (Hospitals, Diagnostic Centers) |
Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered | Abbott (U.S.), Bayer AG (Germany), BD (U.S.), Agilent Technologies, Inc (U.S.), Danaher (U.S.), Hologic, Inc. (U.S.), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthcare Private Limited (Germany), Sysmex Singapore Pte. Ltd. (Singapore), BIOMÉRIEUX (France), DiaSorin Molecular LLC (U.S.), Grifols, S.A. (Spain), Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Leica Biosystems Nussloch GmbH (Germany), Analytik Jena GmbH (Germany), Biocartis (Belgium), GenMark Diagnostics, Inc (U.S.), HTG Molecular Diagnostics, Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Oncology molecular diagnostics detect cancer cells by examining their biological molecules. Several tests on blood, saliva, and tumour tissue samples are performed to detect and measure specific genetic sequences in DNA, RNA, and cell proteins. Oncology molecular diagnostics aid in the rapid analysis and provision of detailed information, which is then used in the personalized treatment of cancer. These diagnostics solutions are used in clinical and point-of-care (POC) testing for cancer detection. Blood banks are also used to identify pathogens and infectious diseases in donated blood samples.
Oncology Molecular Diagnostic Market Dynamics
Drivers
- Rising prevalence of cancer cases
The rising prevalence of cancer cases around the world is driving up demand for diagnosis, which is driving up the oncology molecular diagnostics market. Cancer was responsible for approximately 10 million deaths in 2020, according to the World Health Organization (WHO). Furthermore, according to the American Cancer Society's 2021 statistics, the global burden of cancer is expected to rise to 27.5 million new cases and 16.3 million cancer deaths by 2040. Such high figures suggest that the estimated rising prevalence of cancer is contributing to the growing need for early detection and preventive medicine. As a result of the abovementioned factors, the demand for oncology molecular diagnostic is steadily increasing.
Opportunities
- New advancements in molecular diagnostics tests
As diagnostic testing technology advances, molecular diagnostics tests for oncology are becoming more popular. Several passages are being made in cancer genome sequencing, computational analysis, tumour models, and innovative cancer research methods. For instance, Roche Molecular Systems, Inc. developed the Cobas EGFR Mutation Test for non-small cell lung cancer patients, which received FDA approval in 2020 and is a real-time PCR test that detects 42 mutations in the epidermal growth factor receptor (EGFR) gene.
Key Coverage in the Oncology Molecular Diagnostic Market Report:
- Detailed analysis of Global Oncology Molecular Diagnostic Market by a thorough assessment of the technology, product type, application, and other key segments of the report
- Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period
- Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth
- Comprehensive analysis of the regions of the Oncology Molecular Diagnostic Market and their futuristic growth outlook
- Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies
Why choose Data Bridge Market Research?
- Modern technologies, such as artificial intelligence, to provide updated industry growth.
- DBMR team provides clients with the top notch Oncology Molecular Diagnostic Market research report.
- Interaction with research scientists and development heads to understand the nature of the Oncology Molecular Diagnostic Market more precisely.
- 24/7 availability of services.
- Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective with Forecast period.
DBMR team uses very fair means to gather information that is scrutinized at every stage while structuring an influential Oncology Molecular Diagnostic Market size
Browse Related Reports:
Mini Light-Emitting Diode (LED) Market Size, Analysis and Forecast
Grow Light for Poultry Farming Market Size, Share, Trends Forecast
Catalytic Converter Market Size And Share Analysis Report,
Adhesion Promoter Market by Size, Share, Forecast, Trends
Greenhouse Film Market Size Report- Industry Growth Analysis
Silicone Gel Market Size, Industry Share Forecast
Precision Aquaculture Market Size, Share, Growth | Opportunities,
Maleic Anhydride Market Size, Share Analysis Report
Medical Adhesives Market Size, Share, Growth Analysis
Fiberglass Fabric Market Size, Share, Growth
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
"
